Socialiya - Entertainment. Knowledge. Community.
Moderna enters in vivo CAR-T, granting autoimmune asset ‘007’ license to kill pathogenic cells

Moderna has unveiled its first in vivo CAR-T program. Building on other groups' ex vivo CAR-T data,...

BUSINESS NEWS June 26, 2026

Moderna enters in vivo CAR-T, granting autoimmune asset ‘007’ license to kill pathogenic cells

Moderna has unveiled its first in vivo CAR-T program. Building on other groups' ex vivo CAR-T data, the company plans to start clinical development of an...

2 views 0 likes 0 comments
Share:
Moderna has unveiled its first in vivo CAR-T program. Building on other groups' ex vivo CAR-T data, the company plans to start clinical development of an...

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
APNA POS
Advertisement
socialiya
Advertisement

Top Categories

Advertisement
APNA POS
Advertisement
APNA POS
Advertisement
APNA POS
Advertisement
socialiya